Tag Archive for ‘NVAX’ 
Stock Alert for Novavax Inc. (NVAX)
Novavax Inc. (NVAX) is a clinical-stage biopharmaceutical company creating novel vaccines to address a broad range of infectious diseases worldwide, using advanced proprietary virus-like particle (VLP) technology. The Company produces potent VLP-based recombinant vaccines utilizing new and efficient manufacturing approaches. NVAX is committed to using its VLP technology to create country-specific vaccine solutions. The Company has formed a joint venture - Continue Reading »
